Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax to Present COVID-19, Influenza and RSV Candidate Vaccine Data at World Vaccine Congress Washington 2020
- COVID-19
Sep 28, 2020
Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
- COVID-19
Sep 24, 2020
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax’ Global Production Capacity to Over 2 Billion Doses Annually
- COVID-19
Sep 15, 2020
Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine
- COVID-19
Sep 2, 2020
Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine
- COVID-19
Aug 31, 2020
Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
- COVID-19
Aug 24, 2020
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
- COVID-19
Aug 17, 2020
Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate
- COVID-19
Aug 14, 2020
Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate
- COVID-19
Aug 13, 2020
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
- COVID-19
Aug 4, 2020

Show per page